Table II.
OS | ||
---|---|---|
Variables | Hazard ratio (95% confidence interval) | P-value |
MicroRNA-500 (high vs. low) | 0.563 (0.330–0.961) | 0.035 |
Age (<60 vs. ≥ 60 years) | 1.448 (0.807–2.599) | 0.215 |
White blood cell count (<30 vs. ≥30×109/l) | 0.996 (0.585–1.694) | 0.988 |
Fms-related tyrosine kinase 3 mutation | 0.624 (0.333–1.170) | 0.141 |
Nucleophosmin 1 mutation | 1.099 (0.598–2.019) | 0.761 |
DNA methyltransferase 3 mutation | 0.757 (0.410–1.398) | 0.374 |
WT1 transcription factor mutation | 0.590 (0.276–1.262) | 0.174 |
Runt-related transcription factor 1 mutation | 0.431 (0.201–0.927) | 0.031 |
Tumor protein 53 mutation | 0.255 (0.087–0.750) | 0.013 |
PHD finger protein 6 mutation | 0.321 (0.114–0.906) | 0.032 |
Lysine methyltransferase 2A mutation | 0.309 (0.110–0.869) | 0.026 |
OS, overall survival.